Less Ads, More Data, More Tools Register for FREE

CORRECTED-Approval of Oxford/AstraZeneca COVID shot could help relax COVID restrictions, minister says

Mon, 28th Dec 2020 08:03

(Corrects vaccine maker in paragraph 2)

LONDON, Dec 28 (Reuters) - British regulatory approval of a
COVID-19 vaccine candidate developed by Oxford University and
AstraZeneca could accelerate the lifting of COVID-19
restrictions, cabinet office minister Michael Gove said on
Monday.

Gove said that the independent regulator had to assess the
vaccine, but if it was approved there would be a "significant
increase" in vaccine available. Britain is already rolling out a
vaccine developed by Pfizer and BioNTech.

"If we do get the authorization for that vaccine, and the
rollout goes according to plan, then we will be able to
progressively lift some of the restrictions, which have made
life so difficult for so many," he told Sky News.
(Reporting by Alistair Smout, editing by Louise Heavens)

Related Shares

More News
12 Jun 2024 20:56

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

10 Jun 2024 09:10

LONDON BROKER RATINGS: JPMorgan cuts Aviva but lifts M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

10 Jun 2024 08:30

TOP NEWS: Astra's Tagrisso gets US priority review for lung cancer

(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of no...

10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's lat...

10 Jun 2024 06:25

London pre-open: Stocks set for lower start after EU elections

(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but abo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.